Status:
COMPLETED
Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy
Lead Sponsor:
University of Utah
Conditions:
Macular Dystrophy, Corneal
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to investigate whether taking 4-methylpyrazole (4-MP, fomepizole, Antizol™) inhibits dark adaptation of the eye. In other words, we are testing if 4-MP slows the processin...
Eligibility Criteria
Inclusion
- All nonpregnant, nonlactating adults with normal vision in both eyes
Exclusion
- Previous ocular pathologies
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00346853
Start Date
November 1 2005
End Date
September 1 2006
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moran Eye Center, University of Utah
Salt Lake City, Utah, United States, 84132